Oxtex appoints new CEO
Oxtex has appointed Sanjiv Kanwar as its new CEO, who previously has held leadership roles in a range of international companies – most recently as the Managing Director of Polaris BioPharma, a specialist advisory company to the clinical research industry.
Chris Towler, Interim Chairman, of Oxtex, commented: “On behalf of the entire company, I warmly welcome Sanjiv to Oxtex and we are thrilled to have attracted such an accomplished industry executive to the Oxtex Team. Sanjiv has more than 29 years of experience across clinical medicine/research, diagnostics and the bio-pharmaceutical R&D industry. His track record of delivery in these industries is well-evidenced and he joins Oxtex at a time of significant growth and acceleration in our development and commercial programmes and we look forward to working with Sanjiv on our important mission to deliver innovative tissue expander solutions to surgeons to support their patients unmet needs.”
You can read Sanjiv's biography, and those of members of the Board here.